Answers are grounded in this paper and cite their sources.
Somapacitan showed similar efficacy and safety in patients who continued somapacitan treatment and those who switched from daily GH to somapacitan. Once-weekly injections may lead to a reduced treatment burden relative to once-daily injections. A plain-language summary of this work is available.
No takes yet. Share an insight, caveat, or question.
Sävendahl et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: